研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2022 年 · SiM
Statistics in Medicine,2022 年发表的 302 篇,新的在前。点标题看作者和摘要。回到 2022 年
- Cox models with time‐varying covariates and partly‐interval censoring–A maximum penalised likelihood approach · SiM · 2022-12-30 · 在第 1 页
- A likelihood‐based sensitivity analysis for publication bias on the summary receiver operating characteristic in meta‐analysis of diagnostic test accuracy · SiM · 2022-12-30 · 在第 1 页
- Optimization of the two‐stage group sequential three‐arm gold‐standard design for non‐inferiority trials · SiM · 2022-12-28 · 在第 1 页
- Coupling an individual adaptive‐decision model with a SIRV model of influenza vaccination reveals new insights for epidemic control · SiM · 2022-12-28 · 在第 1 页
- Estimation and visualization of heterogeneous treatment effects for multiple outcomes · SiM · 2022-12-27 · 在第 1 页
- Estimating the distribution of ratio of paired event times in phase II oncology trials · SiM · 2022-12-27 · 在第 1 页
- Analyzing dental fluorosis data using a novel Bayesian model for clustered longitudinal ordinal outcomes with an inflated category · SiM · 2022-12-27 · 在第 1 页
- Power analyses for stepped wedge designs with multivariate continuous outcomes · SiM · 2022-12-24 · 在第 1 页
- Joint regression modelling of intensity and timing of accelerometer counts · SiM · 2022-12-23 · 在第 1 页
- Dealing with confounding in observational studies: A scoping review of methods evaluated in simulation studies with single‐point exposure · SiM · 2022-12-23 · 在第 1 页
- A novel robust estimation for high‐dimensional precision matrices · SiM · 2022-12-23 · 在第 1 页
- A systematic review and evaluation of statistical methods for group variable selection · SiM · 2022-12-22 · 在第 1 页
- Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies · SiM · 2022-12-20 · 在第 1 页
- A Bayesian multilevel time‐varying framework for joint modeling of hospitalization and survival in patients on dialysis · SiM · 2022-12-20 · 在第 1 页
- Bayesian meta‐analytical methods to incorporate multiple surrogate endpoints in drug development process · SiM · 2022-12-14 · 在第 1 页
- Refined moderation analysis with categorical outcomes in precision medicine · SiM · 2022-12-13 · 在第 1 页
- Consistent inverse probability of treatment weighted estimation of the average treatment effect with mismeasured time‐dependent confounders · SiM · 2022-12-13 · 在第 1 页
- An exact regression‐based approach for the estimation of natural direct and indirect effects with a binary outcome and a continuous mediator · SiM · 2022-12-13 · 在第 1 页
- Semi‐supervised clustering of quaternion time series: Application to gait analysis in multiple sclerosis using motion sensor data · SiM · 2022-12-12 · 在第 1 页
- Mediation analysis with multiple mediators under unmeasured mediator‐outcome confounding · SiM · 2022-12-11 · 在第 2 页
- Goodness‐of‐fit test for a parametric mixture cure model with partly interval‐censored data · SiM · 2022-12-07 · 在第 2 页
- Optimal confidence intervals for the relative risk and odds ratio · SiM · 2022-12-05 · 在第 2 页
- Point estimation for adaptive trial designs I: A methodological review · SiM · 2022-11-30 · 在第 2 页
- A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time · SiM · 2022-11-29 · 在第 3 页
- Spatially informed Bayesian neural network for neurodegenerative diseases classification · SiM · 2022-11-28 · 在第 3 页
- Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcome · SiM · 2022-11-28 · 在第 3 页
- Generalized mean residual life models for survival data with missing censoring indicators · SiM · 2022-11-27 · 在第 3 页
- RECeUS: Ratio estimation of censored uncured subjects, a different approach for assessing cure model appropriateness in studies with long‐term survivors · SiM · 2022-11-25 · 在第 3 页
- Practical implementation of the partial ordering continual reassessment method in a Phase I combination‐schedule dose‐finding trial · SiM · 2022-11-25 · 在第 3 页
- Bayesian additive regression trees for multivariate skewed responses · SiM · 2022-11-25 · 在第 3 页
- Adjusting for treatment selection in phase II/III clinical trials with time to event data · SiM · 2022-11-23 · 在第 3 页
- Two‐sample test withg‐modeling and its applications · SiM · 2022-11-22 · 在第 3 页
- Measures of explained variation under the mixture cure model for survival data · SiM · 2022-11-22 · 在第 3 页
- Double robust estimation of optimal partially adaptive treatment strategies: An application to breast cancer treatment using hormonal therapy · SiM · 2022-11-21 · 在第 3 页
- Comparing and combining data from immune assays based on left‐censored multivariate normal model assuming common assay differences across settings · SiM · 2022-11-20 · 在第 3 页
- Target estimands for population‐adjusted indirect comparisons · SiM · 2022-11-17 · 在第 3 页
- Some considerations on target estimands for health technology assessment · SiM · 2022-11-17 · 在第 3 页
- Explicit underdose control based on toxicity: Four points to consider · SiM · 2022-11-17 · 在第 3 页
- Using a surrogate with heterogeneous utility to test for a treatment effect · SiM · 2022-11-13 · 在第 4 页
- Addressing positivity violations in causal effect estimation using Gaussian process priors · SiM · 2022-11-06 · 在第 4 页
- Sample size determination for the association between longitudinal and time‐to‐event outcomes using the joint modeling time‐dependent slopes parameterization · SiM · 2022-10-28 · 在第 5 页
- Overall assessment for selected markers from high‐throughput data · SiM · 2022-10-21 · 在第 5 页
- Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression · SiM · 2022-10-19 · 在第 5 页
- Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs · SiM · 2022-10-17 · 在第 5 页
- Review and evaluation of imputation methods for multivariate longitudinal data with mixed‐type incomplete variables · SiM · 2022-10-11 · 在第 5 页
- Multi‐threshold proportional hazards model and subgroup identification · SiM · 2022-10-05 · 在第 6 页
- A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data · SiM · 2022-10-05 · 在第 6 页
- On the use of the likelihood ratio test methodology in pharmacovigilance · SiM · 2022-09-30 · 在第 6 页
- Bayesian local exchangeability design for phase II basket trials · SiM · 2022-09-30 · 在第 7 页
- A flexible‐hazards cure model with application to patients with soft tissue sarcoma · SiM · 2022-09-27 · 在第 7 页
- Gaussian graphical models with applications to omics analyses · SiM · 2022-09-26 · 在第 7 页
- A simulated maximum likelihood procedure for analyzing imprecise trade‐off thresholds between the benefits and harms of medicines · SiM · 2022-09-26 · 在第 7 页
- Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model · SiM · 2022-09-25 · 在第 7 页
- Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths · SiM · 2022-09-23 · 在第 7 页
- Regression analysis for covariate‐adaptive randomization: A robust and efficient inference perspective · SiM · 2022-09-22 · 在第 7 页
- Conditional probability and ratio‐based approaches for mapping the coverage of multi‐dose vaccines · SiM · 2022-09-21 · 在第 7 页
- Case studies in bias reduction and inference for electronic health record data with selection bias and phenotype misclassification · SiM · 2022-09-21 · 在第 7 页
- Optimal subsampling for parametric accelerated failure time models with massive survival data · SiM · 2022-09-20 · 在第 7 页
- BOB: Bayesian optimal design for biosimilar trials with co‐primary endpoints · SiM · 2022-09-20 · 在第 7 页
- Analytical methods for correlated data arising from multicenter hearing studies · SiM · 2022-09-20 · 在第 7 页
- Dynamic semiparametric transformation models for recurrent event data with a terminal event · SiM · 2022-09-19 · 在第 8 页
- Robust analysis of cancer heterogeneity for high‐dimensional data · SiM · 2022-09-18 · 在第 8 页
- Marginal semiparametric transformation models for clustered multivariate competing risks data · SiM · 2022-09-18 · 在第 8 页
- Group sequential methods for interim monitoring of randomized clinical trials with time‐lagged outcome · SiM · 2022-09-18 · 在第 8 页
- Progression models for repeated measures: Estimating novel treatment effects in progressive diseases · SiM · 2022-09-17 · 在第 8 页
- A note regarding alternative explanations for heterogeneity in meta‐analysis · SiM · 2022-09-16 · 在第 8 页
- Stratified proportional win‐fractions regression analysis · SiM · 2022-09-14 · 在第 8 页
- Contrast weighted learning for robust optimal treatment rule estimation · SiM · 2022-09-14 · 在第 8 页
- Lq‐based robust analytics on ultrahigh and high dimensional data · SiM · 2022-09-13 · 在第 8 页
- Identifying surrogate markers in real‐world comparative effectiveness research · SiM · 2022-09-05 · 在第 8 页
- On estimation and cross‐validation of dynamic treatment regimes with competing risks · SiM · 2022-09-02 · 在第 8 页
- Bias correction based on weighted likelihood for conditional estimation of subgroup effects in randomized clinical trials · SiM · 2022-09-02 · 在第 8 页
- Predictive signature development based on maximizing the area between receiver operating characteristic curves · SiM · 2022-08-31 · 在第 8 页
- Dynamic modeling of the Italians' attitude towards Covid‐19 · SiM · 2022-08-31 · 在第 8 页
- DL 101: Basic introduction to deep learning with its application in biomedical related fields · SiM · 2022-08-30 · 在第 8 页
- A function‐based approach to model the measurement error in wearable devices · SiM · 2022-08-29 · 在第 9 页
- Network meta‐analysis of rare events using penalized likelihood regression · SiM · 2022-08-26 · 在第 9 页
- Synthesizing studies for comparing different treatment sequences in clinical trials · SiM · 2022-08-25 · 在第 9 页
- Noninferiority testing with censoring when the event rate is low · SiM · 2022-08-22 · 在第 9 页
- Online two‐way estimation and inference via linear mixed‐effects models · SiM · 2022-08-19 · 在第 9 页
- Single‐stage, three‐arm, adaptive test strategies for non‐inferiority trials with an unstable reference · SiM · 2022-08-18 · 在第 9 页
- Flexible propensity score estimation strategies for clustered data in observational studies · SiM · 2022-08-18 · 在第 9 页
- Paired serial limiting dilution assays · SiM · 2022-08-17 · 在第 9 页
- Comparison of treatments with ordinal responses in trials with sequential monitoring and response‐adaptive randomization · SiM · 2022-08-16 · 在第 9 页
- Causal discoveries for high dimensional mixed data · SiM · 2022-08-15 · 在第 9 页
- Classification model with weighted regularization to improve the reproducibility of neuroimaging signature selection · SiM · 2022-08-14 · 在第 9 页
- Communication‐efficient estimation and inference for high‐dimensional quantile regression based on smoothed decorrelated score · SiM · 2022-08-13 · 在第 9 页
- Substantive model compatible multilevel multiple imputation: A joint modeling approach · SiM · 2022-08-12 · 在第 9 页
- Doubly robust estimation of optimal dynamic treatment regimes with multicategory treatments and survival outcomes · SiM · 2022-08-10 · 在第 9 页
- A flexible approach for causal inference with multiple treatments and clustered survival outcomes · SiM · 2022-08-10 · 在第 9 页
- Fast Lasso‐type safe screening for Fine‐Gray competing risks model with ultrahigh dimensional covariates · SiM · 2022-08-09 · 在第 9 页
- Weighted generalized score test for comparing predictive values in the presence of verification bias · SiM · 2022-08-05 · 在第 10 页
- Use of copula to model within‐study association in bivariate meta‐analysis of binomial data at the aggregate level: A Bayesian approach and application to surrogate endpoint evaluation · SiM · 2022-08-05 · 在第 10 页
- Calculating the power to examine treatment‐covariate interactions when planning an individual participant data meta‐analysis of randomized trials with a binary outcome · SiM · 2022-08-05 · 在第 10 页
- Semiparametric analysis of a generalized linear model with multiple covariates subject to detection limits · SiM · 2022-07-31 · 在第 10 页
- Multiple imputation and test‐wise deletion for causal discovery with incomplete cohort data · SiM · 2022-07-31 · 在第 10 页
- Design and analysis of cluster randomized trials with time‐to‐event outcomes under the additive hazards mixed model · SiM · 2022-07-31 · 在第 10 页
- Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm · SiM · 2022-07-31 · 在第 10 页
- Fixed‐effects inference and tests of correlation for longitudinal functional data · SiM · 2022-07-30 · 在第 10 页
- Bayesian analysis for partly linear Cox model with measurement error and time‐varying covariate effect · SiM · 2022-07-28 · 在第 10 页
- Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships · SiM · 2022-07-27 · 在第 10 页
- Capturing the pool dilution effect in group testing regression: A Bayesian approach · SiM · 2022-07-25 · 在第 11 页
- Bayesian criterion‐based assessments of recurrent event models with applications to commercial truck driver behavior studies · SiM · 2022-07-24 · 在第 11 页
- A Bayesian modified Ising model for identifying spatially variable genes from spatial transcriptomics data · SiM · 2022-07-24 · 在第 11 页
- Sample size methods for evaluation of predictive biomarkers · SiM · 2022-07-20 · 在第 11 页
- Modeling and forecasting of at home activity in older adults using passive sensor technology · SiM · 2022-07-20 · 在第 12 页
- Targeted maximum likelihood estimation of causal effects with interference: A simulation study · SiM · 2022-07-18 · 在第 12 页
- Rank‐based Bayesian variable selection for genome‐wide transcriptomic analyses · SiM · 2022-07-18 · 在第 12 页
- A calibration approach to transportability and data‐fusion with observational data · SiM · 2022-07-18 · 在第 12 页
- Bayesian unanchored additive models for component network meta‐analysis · SiM · 2022-07-17 · 在第 12 页
- Envelope‐based partial partial least squares with application to cytokine‐based biomarker analysis for COVID‐19 · SiM · 2022-07-15 · 在第 12 页
- Bootstrap vs asymptotic variance estimation when using propensity score weighting with continuous and binary outcomes · SiM · 2022-07-15 · 在第 12 页
- Estimating cumulative spatial risk over time with low‐rank kriging multiple membership models · SiM · 2022-07-11 · 在第 12 页
- Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation · SiM · 2022-07-11 · 在第 12 页
- Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation · SiM · 2022-07-09 · 在第 12 页
- Modeling multivariate age‐related imaging variables with dependencies · SiM · 2022-07-07 · 在第 12 页
- Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models · SiM · 2022-07-07 · 在第 12 页
- Defining R‐squared measures for mixed‐effects location scale models · SiM · 2022-07-07 · 在第 13 页
- CAPITAL: Optimal subgroup identification via constrained policy tree search · SiM · 2022-07-07 · 在第 13 页
- Adaptive response‐dependent two‐phase designs: Some results on robustness and efficiency · SiM · 2022-07-07 · 在第 13 页
- Controlled variable selection in Weibull mixture cure models for high‐dimensional data · SiM · 2022-07-06 · 在第 13 页
- Bayesian network mediation analysis with application to the brain functional connectome · SiM · 2022-07-06 · 在第 13 页
- Accommodating population differences when validating risk prediction models · SiM · 2022-07-05 · 在第 13 页
- Unified estimation for Cox regression model with nonmonotone missing at random covariates · SiM · 2022-07-04 · 在第 13 页
- Analysis of stepped wedge cluster randomized trials in the presence of a time‐varying treatment effect · SiM · 2022-06-30 · 在第 13 页
- Augmented weighting estimators for the additive rates model under multivariate recurrent event data with missing event type · SiM · 2022-06-28 · 在第 13 页
- Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices · SiM · 2022-06-27 · 在第 13 页
- Bayesian nonparametric inference for the overlap coefficient: With an application to disease diagnosis · SiM · 2022-06-27 · 在第 13 页
- Estimands for factorial trials · SiM · 2022-06-25 · 在第 13 页
- Model‐based Bayesian inference under computer assisted balance‐improving designs · SiM · 2022-06-24 · 在第 13 页
- Improved nonparametric penalized maximum likelihood estimation for arbitrarily censored survival data · SiM · 2022-06-24 · 在第 13 页
- Estimating the longitudinal trajectory of cognitive function measurement using short‐term data with different disease stages: Application in Alzheimer's disease · SiM · 2022-06-24 · 在第 13 页
- Restricted mean survival time regression model with time‐dependent covariates · SiM · 2022-06-23 · 在第 13 页
- Transfer learning in high‐dimensional semiparametric graphical models with application to brain connectivity analysis · SiM · 2022-06-21 · 在第 13 页
- Dynamic downscaling and daily nowcasting from influenza surveillance data · SiM · 2022-06-19 · 在第 13 页
- On a reparameterization of a flexible family of cure models · SiM · 2022-06-18 · 在第 13 页
- Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding · SiM · 2022-06-18 · 在第 14 页
- Deep reinforcement learning for personalized treatment recommendation · SiM · 2022-06-18 · 在第 14 页
- Statistical tests for two‐stage adaptive seamless design using short‐ and long‐term binary outcomes · SiM · 2022-06-17 · 在第 14 页
- Using principal stratification in analysis of clinical trials · SiM · 2022-06-13 · 在第 14 页
- Similarity of competing risks models with constant intensities in an application to clinical healthcare pathways involving prostate cancer surgery · SiM · 2022-06-13 · 在第 14 页
- Sample size calculation for randomized selection trials with a time‐to‐event endpoint and a margin of practical equivalence · SiM · 2022-06-10 · 在第 14 页
- Markov neighborhood regression for statistical inference of high‐dimensional generalized linear models · SiM · 2022-06-10 · 在第 14 页
- Uncertainty in lung cancer stage for survival estimation via set‐valued classification · SiM · 2022-06-08 · 在第 14 页
- Toward evaluation of disseminated effects of medications for opioid use disorder within provider‐based clusters using routinely‐collected health data · SiM · 2022-06-08 · 在第 14 页
- Competing risks predictions with different time scales under the additive risk model · SiM · 2022-06-07 · 在第 14 页
- Spike‐and‐slab least absolute shrinkage and selection operator generalized additive models and scalable algorithms for high‐dimensional data analysis · SiM · 2022-06-05 · 在第 14 页
- Extending the Continual Reassessment Method to accommodate step‐up dosing in Phase I trials · SiM · 2022-06-05 · 在第 14 页
- Evaluating effectiveness of public health intervention strategies for mitigating COVID‐19 pandemic · SiM · 2022-06-05 · 在第 14 页
- A straightforward meta‐analysis approach for oncology phase I dose‐finding studies · SiM · 2022-06-05 · 在第 14 页
- Net‐benefit regression with censored cost‐effectiveness data from randomized or observational studies · SiM · 2022-06-03 · 在第 14 页
- Differential expression of single‐cell RNA‐seq data using Tweedie models · SiM · 2022-06-02 · 在第 14 页
- Bayesian inference for discretely observed continuous time multi‐state models · SiM · 2022-05-30 · 在第 15 页
- Versatile tests for window mean survival time · SiM · 2022-05-25 · 在第 15 页
- Multilevel hybrid principal components analysis for region‐referenced functional electroencephalography data · SiM · 2022-05-25 · 在第 15 页
- Self‐reporting and screening: Data with right‐censored, left‐censored, and complete observations · SiM · 2022-05-24 · 在第 15 页
- Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures · SiM · 2022-05-24 · 在第 16 页
- A statistic with demonstrated insensitivity to unmeasured bias for 2 × 2 ×Stables in observational studies · SiM · 2022-05-24 · 在第 16 页
- Propensity score methods for observational studies with clustered data: A review · SiM · 2022-05-23 · 在第 16 页
- A classification for complex imbalanced data in disease screening and early diagnosis · SiM · 2022-05-23 · 在第 16 页
- The batched stepped wedge design: A design robust to delays in cluster recruitment · SiM · 2022-05-21 · 在第 16 页
- The polytomous discrimination index for prediction involving multistate processes under intermittent observation · SiM · 2022-05-20 · 在第 16 页
- Extending multivariate Student's‐t$$ t $$ semiparametric mixed models for longitudinal data with censored responses and heavy tails · SiM · 2022-05-20 · 在第 16 页
- Real time monitoring and prediction of time to endpoint maturation in clinical trials · SiM · 2022-05-19 · 在第 16 页
- Multivariate partial linear varying coefficients model for gene‐environment interactions with multiple longitudinal traits · SiM · 2022-05-18 · 在第 16 页
- Modeling the underlying biological processes in Alzheimer's disease using a multivariate competing risk joint model · SiM · 2022-05-18 · 在第 16 页
- Bayesian inference for asymptomatic COVID‐19 infection rates · SiM · 2022-05-18 · 在第 16 页
- Penalized weighted proportional hazards model for robust variable selection and outlier detection · SiM · 2022-05-17 · 在第 16 页
- Translating questions to estimands in randomized clinical trials with intercurrent events · SiM · 2022-05-16 · 在第 16 页
- Dynamic prediction with time‐dependent marker in survival analysis using supervised functional principal component analysis · SiM · 2022-05-16 · 在第 16 页
- Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure · SiM · 2022-05-16 · 在第 16 页
- The impact of methodological choices when developing predictive models using urinary metabolite data · SiM · 2022-05-14 · 在第 16 页
- Bayesian model of disease progression in mucopolysaccaridosis IIIA · SiM · 2022-05-13 · 在第 16 页
- On optimal biomarker cutoffs accounting for misclassification costs in diagnostic trilemmas with applications to pancreatic cancer · SiM · 2022-05-11 · 在第 16 页
- Surveillance for endemic infectious disease outbreaks: Adaptive sampling using profile likelihood estimation · SiM · 2022-05-08 · 在第 17 页
- Twenty years since Joinpoint 1.0: Two major enhancements, their justification, and impact · SiM · 2022-05-06 · 在第 17 页
- Orthogonal array composite designs for drug combination experiments with applications for tuberculosis · SiM · 2022-05-06 · 在第 17 页
- Self‐matched learning to construct treatment decision rules from electronic health records · SiM · 2022-05-05 · 在第 17 页
- Analyzing cohort studies with interval‐censored data: A new model‐based linear rank‐type test · SiM · 2022-05-05 · 在第 17 页
- Calculating power for the Finkelstein and Schoenfeld test statistic for a composite endpoint with two components · SiM · 2022-04-29 · 在第 17 页
- A robust Bayesian bias‐adjusted random effects model for consideration of uncertainty about bias terms in evidence synthesis · SiM · 2022-04-29 · 在第 17 页
- The number needed to treat adjusted for explanatory variables in regression and survival analysis: Theory and application · SiM · 2022-04-26 · 在第 17 页
- Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring—An application to thin melanoma · SiM · 2022-04-26 · 在第 17 页
- Variable selection in semiparametric regression models for longitudinal data with informative observation times · SiM · 2022-04-25 · 在第 17 页
- Negative binomial factor regression with application to microbiome data analysis · SiM · 2022-04-24 · 在第 17 页
- Robust structured heterogeneity analysis approach for high‐dimensional data · SiM · 2022-04-23 · 在第 17 页
- Statistical power and sample size requirements to detect an intervention by time interaction in four‐level longitudinal cluster randomized trials · SiM · 2022-04-19 · 在第 18 页
- Subgroup‐specific dose finding for phase I‐II trials using Bayesian clustering · SiM · 2022-04-16 · 在第 18 页
- Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates · SiM · 2022-04-16 · 在第 18 页
- Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias · SiM · 2022-04-15 · 在第 18 页
- Improving the performance of Bayesian logistic regression model with overdose control in oncology dose‐finding studies · SiM · 2022-04-15 · 在第 18 页
- Jointly modeling of sleep variables that are objectively measured by wrist actigraphy · SiM · 2022-04-13 · 在第 18 页
- Bayesian sample size determination for diagnostic accuracy studies · SiM · 2022-04-10 · 在第 18 页
- A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies · SiM · 2022-04-10 · 在第 18 页
- How large should the next study be? Predictive power and sample size requirements for replication studies · SiM · 2022-04-08 · 在第 18 页
- Estimation of vaccine efficacy for variants that emerge after the placebo group is vaccinated · SiM · 2022-04-08 · 在第 18 页
- Hierarchical multivariate directed acyclic graph autoregressive models for spatial diseases mapping · SiM · 2022-04-06 · 在第 18 页
- A novel regression method for the analysis of multireader multicase‐free‐response receiver operating characteristics studies · SiM · 2022-04-05 · 在第 19 页
- Nonparametric bounds in two‐sample summary‐data Mendelian randomization: Some cautionary tales for practice · SiM · 2022-03-30 · 在第 19 页
- Limitations of clinical trial sample size estimate by subtraction of two measurements · SiM · 2022-03-30 · 在第 19 页
- Efficient estimation of indirect effects in case‐control studies using a unified likelihood framework · SiM · 2022-03-30 · 在第 19 页
- Inclusion of unexposed clusters improves the precision of fixed effects analysis of stepped‐wedge cluster randomized trials · SiM · 2022-03-29 · 在第 20 页
- Utility based approach in individualized optimal dose selection using machine learning methods · SiM · 2022-03-28 · 在第 20 页
- Regression modeling of restricted mean survival time for left‐truncated right‐censored data · SiM · 2022-03-28 · 在第 20 页
- Reclaiming independence in spatial‐clustering datasets: A series of data‐driven spatial weights matrices · SiM · 2022-03-28 · 在第 20 页
- Multiply robust subgroup analysis based on a single‐index threshold linear marginal model for longitudinal data with dropouts · SiM · 2022-03-28 · 在第 20 页
- Deep learning for the dynamic prediction of multivariate longitudinal and survival data · SiM · 2022-03-28 · 在第 20 页
- A generalized weighted combination test of treatment effect for clinical trials with a sequential parallel comparison design and binary endpoint · SiM · 2022-03-28 · 在第 20 页
- Omnibus testing approach for gene‐based gene‐gene interaction · SiM · 2022-03-26 · 在第 20 页
- Mixed‐type multivariate response regression with covariance estimation · SiM · 2022-03-24 · 在第 20 页
- Marginal, conditional, and pseudo likelihood ratio approaches for biomarker combination to predict a binary disease outcome · SiM · 2022-03-24 · 在第 20 页
- Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model · SiM · 2022-03-23 · 在第 20 页
- Sample size calculation for the augmented logrank test in randomized clinical trials · SiM · 2022-03-23 · 在第 20 页
- Semiparametric multiple inflation count model with application to a smoking cessation study · SiM · 2022-03-22 · 在第 20 页
- Improving large‐scale estimation and inference for profiling health care providers · SiM · 2022-03-22 · 在第 20 页
- Bayesian semi‐parametric modeling of covariance matrices for multivariate longitudinal data · SiM · 2022-03-17 · 在第 21 页
- Quantiles based personalized treatment selection for multivariate outcomes and multiple treatments · SiM · 2022-03-16 · 在第 21 页
- Network meta‐analysis and random walks · SiM · 2022-03-16 · 在第 21 页
- Laplacian‐P‐splines for Bayesian inference in the mixture cure model · SiM · 2022-03-14 · 在第 21 页
- Finite‐sample adjustments in variance estimators for clustered competing risks regression · SiM · 2022-03-14 · 在第 21 页
- Improved estimation in negative binomial regression · SiM · 2022-03-11 · 在第 21 页
- Effect modification in anchored indirect treatment comparison: Comments on “Matching‐adjusted indirect comparisons: Application to time‐to‐event data” · SiM · 2022-03-11 · 在第 21 页
- Group sequential design for randomized trials using “first hitting time” model · SiM · 2022-03-10 · 在第 21 页
- Assessing complier average causal effects from longitudinal trials with multiple endpoints and treatment noncompliance: An application to a study of Arthritis Health Journal · SiM · 2022-03-10 · 在第 21 页
- A semi‐parametric Bayesian model for semi‐continuous longitudinal data · SiM · 2022-03-10 · 在第 21 页
- Association testing for binary trees—A Markov branching process approach · SiM · 2022-03-09 · 在第 21 页
- Bayesian models for aggregate and individual patient data component network meta‐analysis · SiM · 2022-03-08 · 在第 21 页
- A two‐way flexible generalized gamma transformation cure rate model · SiM · 2022-03-08 · 在第 21 页
- The required size of cluster randomized trials of nonpharmaceutical interventions in epidemic settings · SiM · 2022-03-07 · 在第 21 页
- Testing a global null hypothesis using ensemble machine learning methods · SiM · 2022-03-07 · 在第 21 页
- Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states · SiM · 2022-03-07 · 在第 21 页
- A mixture distribution approach for assessing genetic impact from twin study · SiM · 2022-03-07 · 在第 21 页
- Extending the susceptible‐exposed‐infected‐removed (SEIR) model to handle the false negative rate and symptom‐based administration of COVID‐19 diagnostic tests: SEIR‐fansy · SiM · 2022-02-27 · 在第 22 页
- Two decades of statistical education collaboration in the global South: Lessons learned from an Ethiopian project and the way forward · SiM · 2022-02-23 · 在第 22 页
- Statistical advising: Professional development opportunities for the biostatistician · SiM · 2022-02-23 · 在第 22 页
- Sample size estimation using a latent variable model for mixed outcome co‐primary, multiple primary and composite endpoints · SiM · 2022-02-23 · 在第 22 页
- Commentary on training and education in medical statistics, in celebration of 40 years of statistics in medicine and 50 years of the MSc medical statistics at LSHTM · SiM · 2022-02-23 · 在第 22 页
- A multivariate parametric empirical Bayes screening approach for early detection of hepatocellular carcinoma using multiple longitudinal biomarkers · SiM · 2022-02-23 · 在第 22 页
- A Bayesian hierarchical model for individual participant data meta‐analysis of demand curves · SiM · 2022-02-22 · 在第 22 页
- Estimation of the proportion of treatment effect explained by a high‐dimensional surrogate · SiM · 2022-02-21 · 在第 22 页
- Pooling random forest and functional data analysis for biomedical signals supervised classification: Theory and application to electrocardiogram data · SiM · 2022-02-20 · 在第 22 页
- Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design · SiM · 2022-02-20 · 在第 22 页
- IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication · SiM · 2022-02-17 · 在第 23 页
- Common scale minimal sufficient balance: An improved method for covariate‐adaptive randomization based on the Wilcoxon‐Mann‐Whitney odds ratio statistic · SiM · 2022-02-17 · 在第 23 页
- Bayesian two‐stage design for phase II oncology trials with binary endpoint · SiM · 2022-02-17 · 在第 23 页
- Assessing reproducibility of high‐throughput experiments in the case of missing data · SiM · 2022-02-17 · 在第 23 页
- Hypothesis test for causal mediation of time‐to‐event mediator and outcome · SiM · 2022-02-16 · 在第 23 页
- Evaluating the robustness of targeted maximum likelihood estimators via realistic simulations in nutrition intervention trials · SiM · 2022-02-16 · 在第 23 页
- Optimal adaptive promising zone designs · SiM · 2022-02-14 · 在第 23 页
- Inference about ratios of age‐standardized rates with sampling errors in the population denominators for estimating both rates · SiM · 2022-02-14 · 在第 23 页
- Estimating misclassification errors in the reporting of maternal mortality in national civil registration vital statistics systems: A Bayesian hierarchical bivariate random walk model to estimate sensitivity and specificity for multiple countries and years with missing data · SiM · 2022-02-14 · 在第 23 页
- Training and capacity building in medical statistics in Sub‐Saharan Africa: Impact of the London School of Hygiene & Tropical Medicine MSc in Medical Statistics, 1969 to 2021 · SiM · 2022-02-10 · 在第 23 页
- Shared decision making of burdensome surveillance tests using personalized schedules and their burden and benefit · SiM · 2022-02-10 · 在第 23 页
- Constrained randomization and statistical inference for multi‐arm parallel cluster randomized controlled trials · SiM · 2022-02-10 · 在第 23 页
- Sample size calculation for cluster randomized trials with zero‐inflated count outcomes · SiM · 2022-02-09 · 在第 23 页
- A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments · SiM · 2022-02-09 · 在第 23 页
- Model misspecification in stepped wedge trials: Random effects for time or treatment · SiM · 2022-02-08 · 在第 23 页
- Inferring medication adherence from time‐varying health measures · SiM · 2022-02-08 · 在第 23 页
- Robustness of κ‐type coefficients for clinical agreement · SiM · 2022-02-06 · 在第 23 页
- Nonparametric regression with right‐censored covariate via conditional density function · SiM · 2022-02-06 · 在第 23 页
- Bayesian set of best dynamic treatment regimes: Construction and sample size calculation for SMARTs with binary outcomes · SiM · 2022-02-06 · 在第 23 页
- Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration · SiM · 2022-02-03 · 在第 24 页
- Robust inference on effects attributable to mediators: A controlled‐direct‐effect‐based approach for causal effect decomposition with multiple mediators · SiM · 2022-02-02 · 在第 24 页
- Critical issues concerning the assessment sets in agreement assessment · SiM · 2022-02-02 · 在第 24 页
- TITE‐BOIN12: A Bayesian phase I/II trial design to find the optimal biological dose with late‐onset toxicity and efficacy · SiM · 2022-01-31 · 在第 24 页
- Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures · SiM · 2022-01-31 · 在第 25 页
- Sensitivity to missing not at random dropout in clinical trials: Use and interpretation of the trimmed means estimator · SiM · 2022-01-31 · 在第 25 页
- Landmarking 2.0: Bridging the gap between joint models and landmarking · SiM · 2022-01-31 · 在第 25 页
- An efficient penalized estimation approach for semiparametric linear transformation models with interval‐censored data · SiM · 2022-01-31 · 在第 25 页
- A comparison of estimation methods adjusting for selection bias in adaptive enrichment designs with time‐to‐event endpoints · SiM · 2022-01-31 · 在第 25 页
- Preserving data privacy when using multi‐site data to estimate individualized treatment rules · SiM · 2022-01-28 · 在第 25 页
- A modified self‐controlled case series method for event‐dependent exposures and high event‐related mortality, with application to COVID‐19 vaccine safety · SiM · 2022-01-28 · 在第 25 页
- Sample size formula for a win ratio endpoint · SiM · 2022-01-27 · 在第 25 页
- Estimating the health effects of environmental mixtures using principal stratification · SiM · 2022-01-27 · 在第 25 页
- Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data · SiM · 2022-01-26 · 在第 25 页
- Sequential modeling for a class of reference‐based imputation methods in clinical trials with quantitative or binary outcomes · SiM · 2022-01-25 · 在第 25 页
- Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067 · SiM · 2022-01-25 · 在第 25 页
- A nonparametric Bayesian method for dose finding in drug combinations cancer trials · SiM · 2022-01-25 · 在第 25 页
- A multiple testing framework for diagnostic accuracy studies with co‐primary endpoints · SiM · 2022-01-25 · 在第 25 页
- Two‐step hypothesis testing to detect gene‐environment interactions in a genome‐wide scan with a survival endpoint · SiM · 2022-01-24 · 在第 25 页
- Robust nonparametric integrative analysis to decipher heterogeneity and commonality across subgroups using sparse boosting · SiM · 2022-01-24 · 在第 25 页
- Approximate profile likelihood estimation for Cox regression with covariate measurement error · SiM · 2022-01-24 · 在第 25 页
- Conditional or unconditional logistic regression for frequency matched case‐control design? · SiM · 2022-01-23 · 在第 25 页
- Response adaptive intervention allocation in stepped‐wedge cluster randomized trials · SiM · 2022-01-21 · 在第 25 页
- Multiple imputation for longitudinal data using Bayesian lasso imputation model · SiM · 2022-01-21 · 在第 25 页
- Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy · SiM · 2022-01-20 · 在第 25 页
- Causal inference methods for vaccine sieve analysis with effect modification · SiM · 2022-01-19 · 在第 26 页
- An order restricted multi‐arm multi‐stage clinical trial design · SiM · 2022-01-19 · 在第 26 页
- Correcting for partial verification bias in diagnostic accuracy studies: A tutorial using R · SiM · 2022-01-18 · 在第 26 页
- Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules · SiM · 2022-01-18 · 在第 26 页
- Efficient integration of aggregate data and individual participant data in one‐way mixed models · SiM · 2022-01-17 · 在第 26 页
- Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials · SiM · 2022-01-13 · 在第 26 页
- Comparing the accuracy of screening tests with verification of disease status restricted to test positives · SiM · 2022-01-13 · 在第 26 页
- Bayesian hierarchical finite mixture of regression for histopathological imaging‐based cancer data analysis · SiM · 2022-01-13 · 在第 26 页
- Scalable algorithms for semiparametric accelerated failure time models in high dimensions · SiM · 2022-01-11 · 在第 26 页
- Power analysis for stepped wedge trials with multiple interventions · SiM · 2022-01-11 · 在第 26 页
- B‐value and empirical equivalence bound: A new procedure of hypothesis testing · SiM · 2022-01-10 · 在第 26 页
- Bayesian kernel machine regression‐causal mediation analysis · SiM · 2022-01-07 · 在第 26 页
- Optimal sampling for design‐based estimators of regression models · SiM · 2022-01-06 · 在第 26 页
- Statistical considerations for cross‐sectional HIV incidence estimation based on recency test · SiM · 2022-01-04 · 在第 27 页
- Correlated geometric models of order k and its application to intensive care unit and leprosy data · SiM · 2022-01-04 · 在第 27 页
- Sample size calculation in hierarchical 2×2 factorial trials with unequal cluster sizes · SiM · 2022-01-02 · 在第 27 页